SMAD2 and nasopharyngeal carcinoma: INHBB reduces the phosphorylation of Smad2/3 to inhibit EMT, indicating that INHBB may suppress the AR and migratory capacity of nasopharyngeal carcinoma (NPC) cells through the TGF-β/Smads signaling pathway.